HI HCR234

Requests the Drug Enforcement Administration to initiate rescheduling proceedings to remove marijuana from Schedule I controlled substance classification under the Federal Controlled Substances Act.

Argues that marijuana does not meet Schedule I criteria because Hawaii's Medical Marijuana Program, established in 2000, constitutes accepted medical use in the United States, which is required for Schedule I classification.

Cites that Marinol, which contains a naturally occurring component of marijuana, is approved by the FDA and DEA as a Schedule III medication, supporting the claim that marijuana has medical value.

Notes that Hawaii's current medical marijuana program cannot fully comply with federal law due to marijuana's Schedule I status, creating inconsistencies between state and federal law.

Directs certified copies be sent to the U.S. Attorney General, Department of Health and Human Services Secretary, DEA Administrator, Hawaii Governor, and state health and law enforcement officials.